NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Pharmaceutical Retailers · USD

PetMed Express, Inc. (PETS) Stock Analysis

PetMed Express, Inc. (PETS) is a Pharmaceutical Retailers stock listed on NASDAQ and quoted in US Dollar.

PETS

$1.81

−$0.04 (−2.16%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PETS with… →

PETS Key Statistics

As of Sep 4, 2026
Trading
Open
$1.84
Previous Close
$1.85
Day's Range
1.79–1.84
52-Week Range
1.57–4.10
Volume
49.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.79
Valuation
Market Cap
$39.24M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.32
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.23
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.37
Financials (FY)
Revenue (FY)
$179.02M−34.69%
Net Income (FY)
−$57.29M
Profit marginThe share of revenue left as profit after all costs and taxes.
−17.34%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
21.68M
1-Year Return
−40.46%
Dividend and dates
Earnings Date
November 16, 2026estimated
Avg Volume
642.61K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PETS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−43.44%
2025−33.61%
2024−36.24%
2023−54.76%
2022−25.83%
2021−18.17%
2020+41.49%
2019+6.52%
2018−47.35%
2017+102.05%
2016 (partial year)+13.48%

As of September 4, 2026.

PETS Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$179.02M−$57.29M−32.0%
2023$274.10M−$7.46M−2.7%
2022$247.57M$5.14M2.1%
2021$272.28M$18.72M6.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$179.02M$50.22M−$31.42M−$57.29M−32.0%
2023$274.10M$84.77M−$8.16M−$7.46M−2.7%
2022$247.57M$76.50M$6.05M$5.14M2.1%
2021$272.28M$76.94M$24.29M$18.72M6.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

PETS Valuation vs Pharmaceutical Retailers Median

Median of 6 stocks
MetricPETSPharmaceutical Retailers medianvs median
P/S ratio0.230.3431% below
Profit margin−17.34%−11.95%5.4 pts below

Medians across 6 Pharmaceutical Retailers stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values PetMed Express, Inc. (PETS) at $39.24M. It is classified in the Pharmaceutical Retailers industry, within the Healthcare sector. The company reports 189 employees.

Over the past 52 weeks the price has ranged from $1.57 to $4.10. PETS last closed at $1.81 on September 4, 2026. That is −$0.04 (−2.16%) against the previous close. The latest close sits 15.29% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $179.02M. That is −34.69% against the prior fiscal year, when revenue was $274.10M. The same year closed with a net loss of $57.29M. Profit margin runs at −17.34%. That is 5.4 percentage points below the Pharmaceutical Retailers median of −11.95%. Earnings per share on a trailing basis come to −1.37.

Across the 4 fiscal years on file, revenue moves from $272.28M in 2021 to $179.02M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.32. The price-to-sales ratio is 0.23. On price-to-sales that is 30.78% below the Pharmaceutical Retailers median of 0.34. The medians here are taken across 6 Pharmaceutical Retailers companies that report the metric.

The trailing one-year price return is −40.46%. Across 10 years the annualized return works out at −19.07%. The reported beta is 0.79. Annualized volatility over the trailing 10 years is 63.09%.

Growth & Income

No dividend is on file for PETS.

The strongest complete calendar year on file is 2017 at +102.05%; the weakest is 2023 at −54.76%. Of the 9 complete calendar years on file, 3 finished higher. So far in 2026 the price is −43.44%.

Peer Comparison

PetMed Express, Inc. (PETS) operates in the Pharmaceutical Retailers industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
PetMed Express, Inc. PETS $39.24M —
High Tide Inc. HITI $225.39M —
TelyRx Holdings Inc. TELY.TO $65.15M —
Scienture Holdings, Inc. SCNX $15.32M —

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Pharmaceutical Retailers Stocks

HITI

High Tide Inc.

$225.39M

 TELY.TO

TelyRx Holdings Inc.

$65.15M

 SCNX

Scienture Holdings, Inc.

$15.32M

 RDGT

Ridgetech, Inc.

$3.30M
View all Pharmaceutical Retailers stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About PetMed Express, Inc.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Visit website →